Cargando…

USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective

SIMPLE SUMMARY: Elevated levels of ubiquitin-specific protease 7 (USP7) are associated with poor survival in many cancers. This protein impairs the balance of various cellular proteins and regulates the anti-tumor immune response. Its inhibition affects regulatory T cells and tumor-associated macrop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korenev, Georgiy, Yakukhnov, Sergey, Druk, Anastasia, Golovina, Anastasia, Chasov, Vitaly, Mirgayazova, Regina, Ivanov, Roman, Bulatov, Emil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688046/ https://www.ncbi.nlm.nih.gov/pubmed/36428632 http://dx.doi.org/10.3390/cancers14225539

Ejemplares similares

Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry
por: Khadiullina, Raniya, et al.
Publicado: (2022)

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
por: Chasov, Vitaly, et al.
Publicado: (2021)

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
por: Mirgayazova, Regina, et al.
Publicado: (2020)

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020)

Novel Isatin-based activator of p53 transcriptional functions in tumor cells
por: Mirgayazova, Regina, et al.
Publicado: (2019)

Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies
por: Ganeeva, Irina, et al.
Publicado: (2022)

Measurements of Beam Current for Relativistic Electrons in Air by Current Transformers
por: Korenev, S A
Publicado: (2001)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

USP7 substrates identified by proteomics analysis reveal the specificity of USP7
por: Nie, Litong, et al.
Publicado: (2022)

Selective Inhibition of USP7
por: Menard, Robert, et al.
Publicado: (2012)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Current status of cancer immunotherapy
por: Kono, K
Publicado: (2014)

Lymphoma Immunotherapy: Current Status
por: Zappasodi, Roberta, et al.
Publicado: (2015)

Current Status in Rechallenge of Immunotherapy
por: Hu, Han, et al.
Publicado: (2023)

Ecological and Geochemical Conditions for the Accumulation of Antioxidants in the Leaves of Lathyrus maritimus (L.) Bigel
por: Maslennikov, Pavel, et al.
Publicado: (2020)

Molecular mechanism for the substrate recognition of USP7
por: Cheng, Jingdong, et al.
Publicado: (2015)

Targeting melanoma residual disease by USP7
por: Vishnoi, Monika, et al.
Publicado: (2018)

Fbw7 and Usp28 – enemies and allies
por: Taranets, Lyudmyla, et al.
Publicado: (2015)

Highlights in USP7 inhibitors for cancer treatment
por: Oliveira, Rita I., et al.
Publicado: (2022)

Lithium-Cation Conductivity of Solid Solutions in Li(6-x)Zr(2-x)A(x)O(7) (A = Nb, Ta) Systems
por: Shekhtman, Georgiy Sh., et al.
Publicado: (2021)

Immunotherapy in the management of melanoma: current status
por: Alston, Dylan, et al.
Publicado: (2013)

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
por: Xiong, Wenjun, et al.
Publicado: (2022)

TIP60 governs the auto-ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex
por: Ahmad, Tanveer, et al.
Publicado: (2021)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

Identification and Characterization of USP7 Targets in Cancer Cells
por: Georges, Anna, et al.
Publicado: (2018)

USP7 Is a Master Regulator of Genome Stability
por: Valles, Gabrielle J., et al.
Publicado: (2020)

Current status of sublingual immunotherapy in the United States
por: Elenburg, Shelby, et al.
Publicado: (2014)

Current Status and Perspective of Immunotherapy in Gastrointestinal Cancers
por: Kim, Jung Hoon, et al.
Publicado: (2016)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
por: Kitamura, Hiroshi, et al.
Publicado: (2011)

Current status and perspectives in immunotherapy for metastatic melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018)

Current status and future directions of cancer immunotherapy
por: Zhang, Hongming, et al.
Publicado: (2018)

Current status and advances of immunotherapy in nasopharyngeal carcinoma
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
por: Anko, Mayuka, et al.
Publicado: (2021)

Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018)

Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
por: Bulatov, Emil, et al.
Publicado: (2018)

Targeting Cullin–RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
por: Bulatov, Emil, et al.
Publicado: (2015)

Robot-as-a-Service: From Cloud to Peering Technologies
por: Kapitonov, Aleksandr, et al.
Publicado: (2021)

Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11
por: Vlasschaert, Caitlyn, et al.
Publicado: (2015)

USP7/HAUSP stimulates repair of oxidative DNA lesions
por: Khoronenkova, Svetlana V., et al.
Publicado: (2011)

Usp7 protects genomic stability by regulating Bub3
por: Giovinazzi, Serena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pd1b6iaqpsufnd21b3lhflnsda